Quantitative structure activity analysis of 2-alkoxydihydrocinnamates as PPARα/γ dual agonist

Medicinal Chemistry

Volumn 4, Issue 3, 2008, Pages 273-277

  Kumar, P Manoj ^a   Hemalatha, R ^a   Mahajan, S C ^a   Karthikeyan, C ^b   Narayana Moorthy, N S Hari ^b   Trivedi, Piyush ^b  

^a Mahakal Institute of Pharmaceutical Studies   (India)

^b UNIVERSITY INSTITUTE OF TECHNOLOGY   (India)

Author keywords

Diabetes; Dipole moment; Hammett constant; Hansch analysis; Heat of formation; PPAR; PPAR ; QSAR

Indexed keywords

2 ALKOXYDIHYDROCINNAMATE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST;

ARTICLE; DIABETES MELLITUS; DRUG MECHANISM; DRUG RESEARCH; DRUG STRUCTURE; ELECTRON; ELECTRONICS; HYDROPHOBICITY; MOLECULAR MODEL; MULTIPLE LINEAR REGRESSION ANALYSIS; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; THERMODYNAMICS;

CINNAMATES; LINEAR MODELS; PPAR ALPHA; PPAR GAMMA; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; THERMODYNAMICS;

EID: 45149101538     PISSN: 15734064     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340608784325188     Document Type: Article

References (27)

1. Hotamisligil, G.S.; Spiegelman, B.M. Diabetes, 1994, 43, 1272.
2. Shinkai, H. Exp. Opin. Ther. Patents, 2000, 10, 59.
3. John, M.N.; Wagman, A.S. Annu. Rep. Med.Chem., 2000, 35, 211.
4. Desvergne, B.; Wahli, W. Endocr. Rev., 1999, 20, 649.
5. Lee, C.H.; Olson, P.; Evans, R.M. Endocrinology, 2003, 144, 2201.
6. Akiyama, T.E.; Meinke, P.T.; Berger, J.P. Curr. Diabetes Rep., 2005, 5, 45.
7. Wilson, T.M.; Brown, P.J.; Sternbach, D.D.; Henke, B.R. J. Med. Chem., 2000, 4, 527.
8. Verges, B. Diabetes Metab., 2004, 30, 7.
9. Shearer, B.G.; Hoekstra, W.J. Curr. Med. Chem., 2003, 10, 267.
10. Campbell, I.W. Curr. Mol. Med., 2005, 5, 349.
11. Zang, L.; Chawla, A. Trends Endocrinol. Metab., 2004, 10, 500.
12. Walczak, R.; Tontonoz, P. J. Lipid Res., 2002, 43, 177.
13. Methisen, A.L.; Brockley, M.R. Diabetes, 2000, 49(l), A117.
14. Noumura, M.; Kinoshita, S.; Satoh, H.; Maeda, T.; Murakami, K. Bioorg. Med. Chem. Lett., 1999, 9, 533.
15. Torra, I.P.; Gervois, P.; Staels, B. Curr. Opin. Lipidol., 1999, 10, 151.
16. Staels, B.; Dallongeville, J.; Auwerx, J.; Schoonjans, K.; Leitersdorf, E.; Fruchart, J.C. Circulation, 1998, 98, 2088.
17. Pegorier, J.P. Annu. Endocrinol., 2005, 66, IS10.
18. Henke, B.R. J. Med. Chem., 2004, 47, 4118.
19. Ying Lu, Zongru, G.; Yanshen, G.; Jun, F.; Fengming, C. Bioorg. Med. Chem. Lett., 2006, 16, 915.
20. Hansch, C.; Leo, A. Substituent Constants for Correlation Analysis in Chemistry and Biology, Wiley Intersceince, New York, 1979, pp: 48.
21. CS Chem Office, Version 6.0,Cambridge Soft Corporation, Software Publishers Association, 1730 M Street, NW, Suite 700, Washington, D.C. 20036.
22. Keir, L.B. Molecular Orbital Theory in Drug Research, Academic Press, New York, 1971, pp. 62.
23. Gupta, A.K.; Babu, M.A.; Kaskhedikar, S.G. Indian J. Pharm. Sci., 2004, 66, 396.
24. Schaper, K.J. Quant. Struct. Act. Relat., 1999, 18, 354.
25. Wold, S.; Eriksson, L. In Chemometric Methods in Molecular Design, Ed.; Van De Waterbeemd H. VCH: Weinheim, 1995, pp. 321.
26. Hemalatha, R.; Soni, L.K.; Gupta, A.K.; Kaskhedikar, S.G. Indian J. Chem., 2006, 45(B), 1247.
27. Hemalatha, R.; Soni, L.K.; Gupta, A.K.; Kaskhedikar, S.G. E-. J. Chem., 2004, 01(5), 243.